Brief: Angiodynamics Reports Q2 2024 Financial Results; Revises FY2024 Guidance

AngioDynamics

05/01/2024 14:05

Jan 5 (Reuters) - AngioDynamics Inc  ANGO.O :
    * ANGIODYNAMICS REPORTS FISCAL YEAR 2024 SECOND QUARTER
FINANCIAL
RESULTS; REVISES FISCAL YEAR 2024 GUIDANCE
    * EXPECTS TO ACHIEVE FULL-YEAR ADJUSTED EPS PROFITABILITY IN
FY27
    * EXPECTS TO ACHIEVE FULL-YEAR ADJUSTED EPS PROFITABILITY IN
FY27
    * ON NOVEMBER 30, 2023, COMPANY HAD $60.9 MILLION IN CASH
AND CASH
EQUIVALENTS
    * EXPECTS FY GROSS MARGIN TO BE APPROXIMATELY 49% TO 51% AND
ADJUSTED LOSS PER SHARE IN RANGE OF $0.35 TO $0.42
    * : INITIATED RESTRUCTURING OF MANUFACTURING FOOTPRINT AND
TRANSITION TO OUTSOURCED MANUFACTURING
    * : NET SALES FOR Q2 OF FISCAL YEAR 2024 WERE $79.1 MILLION,
AN
INCREASE OF 2.7%
    * RESTRUCTURING IS EXPECTED TO RESULT IN AN APPROXIMATE $15
MILLION ANNUALIZED REDUCTION IN EXPENSES BY FISCAL YEAR 2027
    * ANGIODYNAMICS INC: QTRLY GAAP LOSS PER SHARE OF $0.72

Source text for Eikon:  ID:nBw2NsGQa 
Further company coverage:  ANGO.O 

 ((Reuters.Briefs@thomsonreuters.com;))